Therapeutic outcomes of patients with acute erythroid leukemia treated with hypomethylating agents
Journal of Oncology Pharmacy Practice
Published online on March 03, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
Acute erythroid leukemia treatment is associated with poor survival. The most common treatments are intensive chemotherapy regimens and hypomethylating agents. Choice of preferred therapy is complex, and data are conflicting on the optimal regimen. The ...
Acute erythroid leukemia treatment is associated with poor survival. The most common treatments are intensive chemotherapy regimens and hypomethylating agents. Choice of preferred therapy is complex, and data are conflicting on the optimal regimen. The ...